Viibryd Vilazodone Withdrawal Breakthrough

If you want to taper off the Viibryd and you are not sure where to start, you can click here and read the bestselling book, How to Get Off Psychoactive Drugs Safely or send Jim Harper an email at [email protected] and he will guide you through the process of Viibryd withdrawal.

Viibryd ( Vilazodone ) Withdrawal

If you are experiencing brain zaps, electrical jolts in the head, click here

Viibryd is a brand name for the prescription medication Vilazodone, which is primarily used for the treatment of depression. Developed by Clinical Data, Inc., Viibryd was approved by the US Food and Drug Administration (FDA) in 2011. Since then, it has gained popularity as a safe and effective alternative to other antidepressants.

Viibryd belongs to a class of medications known as selective serotonin reuptake inhibitors (SSRIs) and partial agonists of the serotonin 1A receptor. The drug works by increasing the levels of serotonin in the brain, which is a neurotransmitter that is responsible for regulating mood, appetite, and sleep.

One of the primary advantages of Viibryd is its low incidence of side effects compared to other antidepressants. While most SSRIs are associated with side effects such as weight gain, sexual dysfunction, and drowsiness, Viibryd has been shown to cause significantly fewer side effects in clinical trials.

Some of the most common side effects of Viibryd include diarrhea, nausea, and vomiting. However, these side effects are typically mild and go away on their own after a few days. Less common side effects may include sleep disturbances, dizziness, and dry mouth.

Viibryd is available in tablet form and is typically taken once daily with food. The recommended starting dose is 10 milligrams (mg) per day, which can be increased to 20 mg per day after one week. Patients who do not respond to the 20 mg dose may be increased to 40 mg per day.

Full Description of Viibryd Vilazodone:

Viibryd is a medication that is used to treat major depressive disorder. It is an antidepressant medication that works by increasing the levels of serotonin in the brain. Like any medication, Viibryd can have side effects, and some people may experience withdrawal symptoms when they stop taking it.

Withdrawal symptoms can occur when a person stops taking Viibryd suddenly, or when they taper off the medication too quickly. Withdrawal symptoms can vary in severity and duration, depending on the individual and how long they have been taking the medication. Some common withdrawal symptoms of Viibryd include:

1. Dizziness: Some people may experience dizziness or lightheadedness when they stop taking Viibryd. This can make it difficult to perform daily activities such as driving or working.

2. Nausea: Nausea and vomiting are common withdrawal symptoms of Viibryd. These symptoms can be severe and may last for several days.

3. Insomnia: Some people may experience insomnia or difficulty sleeping when they stop taking Viibryd. This can make it difficult to get a good night’s sleep and can lead to fatigue and other health problems.

4. Anxiety: Viibryd is used to treat anxiety as well as depression, so it is not surprising that some people may experience anxiety when they stop taking the medication. This can include feelings of restlessness, nervousness, and panic.

5. Mood swings: Viibryd can help to stabilize mood, so when people stop taking it, they may experience mood swings or changes in their emotional state. This can include feelings of irritability, sadness, or agitation.

6. Headaches: Some people may experience headaches or migraines when they stop taking Viibryd. These can be mild to severe and can make it difficult to perform daily activities.

Flu-like symptoms: Some people may experience flu-like symptoms when they stop taking Viibryd. These can include fever, chills, and body aches.

If you are experiencing withdrawal symptoms from Viibryd, it is important to talk to your doctor. Your doctor may recommend gradually tapering off the medication to reduce the severity of withdrawal symptoms. They may also prescribe other medications or therapies to help manage withdrawal symptoms.

In conclusion, Viibryd withdrawal can cause a range of symptoms, from mild to severe, and can last for several days or weeks. If you are experiencing withdrawal symptoms, it is important to talk to your doctor to discuss the best course of action. With the proper management and support, it is possible to successfully stop taking Viibryd and manage any withdrawal symptoms that may arise.

Viibryd withdrawal

Viibryd Withdrawal

Get relief from Viibryd insomnia and Viibryd anxiety.

Viibryd withdrawal solution.

Viibryd vilazodone HCI Withdrawal

The F.D.A. estimates 10% of the people withdrawing off an antidepressant will not be able to succeed due to withdrawal side effects. Viibryd is not different. If you are one of the lucky 90% that can do a successful Viibryd withdrawal you still need to rebuild your body once off Viibryd. This site provides information what to do for Viibryd withdrawal and after Viibryd withdrawal if you were able to succeed on your own.

Let’s take at how to have a successful Viibryd withdrawal first. There are two parts that make a successful Viibryd withdrawal possible. How you reduce the Viibryd during withdrawal and taking a few supplements that will help eliminate any Viibryd withdrawal side effects. If you want to read the short version of how to handle Viibryd withdrawal side effects Click here. Page opens new browser window.

It does not matter what dosage of Viibryd you are taking or how long you have used Viibryd; the reduction of Viibryd is the same. You want to reduce Viibryd by no more than 10% and only reduce by an additional 10% every 2 weeks. This is the safest and most successful way to become Viibryd free and not suffer during withdrawal.

Check with your pharmacist for compounding the Viibryd and the best option. The next best method is to use a pill slicer and a milligram scale. Get a 7 day pill holder and once a week cut your pills for the coming week. Roughly 90% of you will be able to complete a Viibryd withdrawal using the method above. However, you will most likely experience flu like symptoms, headache, brain zaps, anxiety, and insomnia or in some cases extreme fatigue. These symptoms will normally last 1 or 2 weeks.

In early 1999, we began investigating the use of natural supplements to help ease withdrawal symptoms. Over the past 20 plus years we have continued to improve this approach and our success rate is rather high. With Viibryd vilazodone HCI withdrawal, you should take 4 supplements. JNK Formula Complete, Neuro Day, Neuro Night and Omega 3 Supreme.

You can read The Program (link above) for all chapters of the bestselling book, How to Get Off Psychoactive Drugs Safely, or just follow the instructions on each bottle to know when to take each supplement. Take the supplements for 1 full week before reducing the Viibryd and then you can begin your Viibryd withdrawal reduction. It really can be this simple. If you are located in the United States Canada, Great Britain Click here

What is Viibryd

Viibryd is a prescription medication used to treat depression and anxiety. It belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). The medication takes some time to build up in the body, which is why it can take a few weeks before people begin noticing a reduction in symptoms of depression or anxiety. If you suddenly stop taking Viibryd, however, you may experience symptoms of withdrawal. In the United States this withdrawal is known as Viibryd Discontinuation Syndrome but in Europe is known as Viibryd Withdrawal. Antidepressants are among the most commonly prescribed medications in the United States. Of the more than 60 million people who take them in a given month, about one quarter have been taking them for more than 10 years. Often, long- term use is linked to fear of relapse of their symptoms or withdrawal. We have found length of time taking Viibryd WILL NOT determine how easy or difficult it will be for you to accomplish a Viibryd withdrawal.

People experience symptoms of Viibryd withdrawal because of the way SSRI’s work in the brain. SSRIs affect the levels of serotonin, a type of mood-regulating neurotransmitter in the brain. When you abruptly stop taking your medication, it doesn’t give the brain enough time to adjust to the sudden change. Whether you are stopping Viibryd because it is not working for you or you are better and you’ve decided with your doctor that it makes sense to come off your medication, the quitting process needs to be slow and gradual.

Recent research has found that the severity of SSRI withdrawal is much worse than previously believed. On average, about 46% of people experiencing SSRI withdrawal symptoms describe them as severe. Severe symptoms indicate that withdrawal can potentially interfere with your ability to meet responsibilities at home and at work.

It was also found that 10% of the people attempting antidepressant withdrawal, 10% quit the Viibryd withdrawal due to a withdrawal side effect known as brain zaps. The Omega 3 Supreme used during Viibryd withdrawal is formulated to ease this severe withdrawal side effect.

Most Common Symptoms

The most common symptoms of Viibryd withdrawal—occurring in more than one in four people—are as follows:


Muscle tension



Trouble concentrating

Trouble remembering things


The most common symptoms of Viibryd withdrawal are dizziness, muscle tension, and chills, which each affect about 44% of users. Many people also experience confusion and difficulty concentrating. Once again, the supplements have been formulated to help with these symptoms.

Complete Symptoms

The following is a more complete list of symptoms associated with withdrawal: Changes in motor control: Tremors, muscle tension, restless legs, unsteady gait, or difficulty controlling speech and chewing movements Digestive issues: Nausea, vomiting, cramps, diarrhea, or appetite loss Flu-like symptoms: Headache, muscle pain, weakness, and tiredness. Instability: Dizziness, lightheadedness, difficulty walking Mood changes: Anxiety, agitation, panic, suicidal ideation, depression, irritability, anger, mania, or mood swings Sleep problems: Nightmares, unusual dreams, excessive/vivid dreams, or insomnia Unusual sensations: Brain zaps (like an electrical shock or shiver in your brain), pins and needles, ringing in the ears, strange tastes, or hypersensitivity to sound.

Viibryd withdrawal can take a real toll on your life, both physically and emotionally. Antidepressants like Viibryd work by increasing serotonin levels in your brain. When you stop taking them, it takes your brain a while to get used to the drug’s absence. Unfortunately, the amount of time this takes can vary widely.

Viibryd withdrawal symptoms typically arrive one to three days after your last dose. It can start sooner (within hours) or later (more than a week). This is why most inpatient facilities fail with Viibryd withdrawal. Insurance may pay only 9 days of treatment and by the time you are off the plane near your city, Viibryd withdrawal is back and in full effect. Viibryd withdrawal should never be rushed.

Coping & Relief

The best way to find relief from Viibryd withdrawal is to use the supplements mentioned above, reduce the Viibryd gradually and only continue to reduce when you are feeling very well. If you are still experiencing symptoms of depression, definitely send us an e-mail and we will help you adjust supplements and assist you in finding the cause.

Taper Off Medication Slowly

In 1999, our founder, Jim Harper, published a guideline for reducing medications. That guideline has been adapted to all psychoactive medications by the drug manufacturers. The most effective way to minimize symptoms of withdrawal is to slowly taper off your medication. “Reduce the medication slowly. If withdrawal symptoms begin go back up to the last dosage you were doing fine at, stay at that dosage until all withdrawal has subsided. When you continue with withdrawal reduce the medication slower than the previous reductions.

”Viibryd should only be reduced by 10%. Some people will need to reduce the Viibryd by 5%. Reductions of the Viibryd can be made every 7 days or in some cases every 14 days. Slow and steady wins this race.

Tapering involves adjusting your dose by a small amount, gradually decreasing until your body gets used to lower levels of the medication. Talk to your doctor who can then create a dose schedule and carefully monitor the process to avoid severe symptoms. Practice Good Self-Care Taking good care of your health as you stop taking Viibryd can also help you to better manage any withdrawal symptoms that you experience.

Some steps you can take that might help you cope with withdrawal symptoms include:

Do not change your diet when tapering. This can alter metabolism rater of the Viibryd and create a withdrawal symptom

Follow your doctor’s tapering recommendations

Get plenty of rest

Get regular mild exercise

Get support from family, friends, or support groups

If you or someone you love shows any of the following signs or symptoms after stopping or during a Viibryd taper, get help:

Becoming preoccupied with death, dying, or violence Engaging in risky or self-destructive activities, such as driving drunk Feeling hopeless or trapped Gathering the means to commit suicide, such as bullets or pills Getting affairs in order or giving away belongings Having intense mood swings

Planning how you would commit suicide if you were going to do it Saying goodbye to people as if it were the last time Talking or thinking about suicide more than normal, for example, “I wish I were dead.”

1. Stuivenga M, Giltay EJ, Cools O, Roosens L, Neels H, Sabbe B. Evaluation of vilazodone for the treatment of depressive and anxiety disorders. Expert Opin Pharmacother. 2019 Feb;20(3):251-260. doi: 10.1080/14656566.2018.1549542. Epub 2018 Nov 26. PMID: 30475091. [cited 2022 June 14]

2. Walsh WJ (2012). Nutrient Power. Skyhorse Publishing, New York, NY. Crayton JW, Walsh WJ (2007). J Trace Elements Med Biol.21:17-21.[cited 2022 June 14]

3. Hillhouse TM, Porter JH. A brief history of the development of antidepressant drugs: from monoamines to glutamate. Exp Clin Psychopharmacol. 2015;23(1):1-21. doi:10.1037/a0038550 [cited 2022 June 14]

4. Knapen J, Vancampfort D, Moriën Y, Marchal Y. Exercise therapy improves both mental and physical health in patients with major depression. Disabil Rehabil. 2015;37(16):1490-5. doi: 10.3109/09638288.2014.972579. Epub 2014 Oct 24. PMID: 25342564. [cited 2022 June 14]

5. Cuomo A, Maina G, Bolognesi S, Rosso G, Beccarini Crescenzi B, Zanobini F, Goracci A, Facchi E, Favaretto E, Baldini I, Santucci A, Fagiolini A. Prevalence and Correlates of Vitamin D Deficiency in a Sample of 290 Inpatients With Mental Illness. Front Psychiatry. 2019 Mar 29;10:167. doi: 10.3389/fpsyt.2019.00167. PMID: 31001150; PMCID: PMC6455075. [cited 2022 June 14]

6. Rao TS, Asha MR, Ramesh BN, Rao KS. Understanding nutrition, depression and mental illnesses. Indian J Psychiatry. 2008;50(2):77-82. doi:10.4103/0019-5545.42391 [cited 2022 June 14]

7. Briguglio M, Dell’Osso B, Panzica G, et al. Dietary Neurotransmitters: A Narrative Review on Current Knowledge. Nutrients. 2018;10(5):591. Published 2018 May 10. doi:10.3390/nu10050591 [cited 2022 June 14]

8. Pandya CD, Howell KR, Pillai A. Antioxidants as potential therapeutics for neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2013;46:214-223. doi:10.1016/j.pnpbp.2012.10.017 [cited 2022 June 14]

9. Osher Y, Belmaker RH. Omega-3 fatty acids in depression: a review of three studies. CNS Neurosci Ther. 2009 Summer;15(2):128-33. doi: 10.1111/j.1755-5949.2008.00061.x. PMID: 19499625; PMCID: PMC6494070. [cited 2022 June 14]

10. Yeung KS, Hernandez M, Mao JJ, Haviland I, Gubili J. Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho-oncologic relevance. Phytother Res. 2018 May;32(5):865-891. doi: 10.1002/ptr.6033. Epub 2018 Feb 21. PMID: 29464801; PMCID: PMC5938102. [cited 2022 June 14]

11. Firth J, Gangwisch J, Borsini A, Wootten R, Mayar E, Food and Mood – How do Diet and Nutrition Affect Mental Well-being? BMJ 2020;369:m2382 [cited 2022 June 14]

12. Substance Abuse and Mental Health Services Administration. DSM-5 Changes: Implications for Child Serious Emotional Disturbance [Internet]. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2016 Jun. Table 9, DSM-IV to DSM-5 Major Depressive Episode/Disorder Comparison. Available from: [cited 2022 June 14]

13. World Health Organization fact sheet, Depression [published online 13 Sept 2021] [cited 2022 June 14]

14. Treatment-resistant depression: no panacea, many uncertainties. Adverse effects are a major factor in treatment choice. Prescrire Int. 2011 May;20(116):128-33. PMID: 21648180. [cited 2022 June 14]

15. Nanthakumaran S, Sridharan S, Somagutta MR, Arnold AA, May V, Pagad S, Malik BH. The Gut-Brain Axis and Its Role in Depression. Cureus. 2020 Sep 6;12(9):e10280. doi: 10.7759/cureus.10280. PMID: 33042715; PMCID: PMC7538207. [cited 2022 June 14]

16. Prasko J. Bright light therapy. Neuro Endocrinol Lett. 2008 Nov;29 Suppl 1:33-64. PMID: 19029878. [cited 2022 June 14]

17. Ljungberg, Tina et al. “Evidence of the Importance of Dietary Habits Regarding Depressive Symptoms and Depression.” International journal of environmental research and public health vol. 17,5 1616. 2 Mar. 2020, doi:10.3390/ijerph17051616[cited 2022 June 14]

18. David D, Cristea I, Hofmann SG. Why Cognitive Behavioral Therapy Is the Current Gold Standard of PsychotherapyFront Psychiatry. 2018;9:4. Published 2018 Jan 29. doi:10.3389/fpsyt.2018.00004 [cited 2022 June 14]

19. Zell M, Grundmann O. An orthomolecular approach to the prevention and treatment of psychiatric disorders. Adv Mind Body Med. 2012 Fall;26(2):14-28. PMID: 23341413. [cited 2022 June 14]

20. Mason LH, Harp JP, Han DY. Pb neurotoxicity: neuropsychological effects of lead toxicity. Biomed Res Int. 2014;2014:840547. doi: 10.1155/2014/840547. Epub 2014 Jan 2. PMID: 24516855; PMCID: PMC3909981. [cited 2022 June 14]

21. Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, Toppari J, Zoeller RT. EDC-2: The Endocrine Society’s Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev. 2015 Dec;36(6):E1-E150. doi: 10.1210/er.2015-1010. Epub 2015 Nov 6. PMID: 26544531; PMCID: PMC4702494. [cited 2022 June 14]

22. Sharma A, Madaan V, Petty FD. Exercise for mental healthPrim Care Companion J Clin Psychiatry. 2006;8(2):106. doi:10.4088/pcc.v08n0208a [cited 2022 June 14]